The impact of phospholipid transfer protein (PLTP) on lipoprotein metabolism

Nutrition and Metabolism

Volumn 9, Issue , 2012, Pages

  Jiang, Xian Cheng ^a   Jin, Weijun ^a   Hussain, Mahmood M ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN; APOLIPOPROTEIN B; APOLIPOPROTEIN F; CHENODEOXYCHOLIC ACID; CHOLESTERY ESTER TRANSFER PROTEIN; FARNESOID X RECEPTOR; FENOFIBRATE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LIVER X RECEPTOR; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHOSPHOLIPID TRANSFER PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; ENDOPLASMIC RETICULUM; HUMAN; LIPID DIET; LIPOPROTEIN METABOLISM; MACROPHAGE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84864954440     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-9-75     Document Type: Review

References (89)

1. The implications of the structure of the bactericidal/permeability- increasing protein on the lipid-transfer function of the cholesteryl ester transfer protein. Bruce C, Beamer LJ, Tall AR, Curr Opin Struct Biol 1998 8 426 434 10.1016/S0959-440X(98)80118-8 9729732 (Pubitemid 28409950)
2. Complete cDNA encoding human phospholipid transfer protein from human endothelial cells. Day JR, Albers JJ, Lofton-Day CE, Gilbert TL, Ching AF, Grant FJ, O'Hara PJ, Marcovina SM, Adolphson JL, J Biol Chem 1994 269 9388 9391 8132678 (Pubitemid 24209271)
3. Measurement and prediction of the rates of spontaneous transfer of phospholipids between plasma lipoproteins. Massey JB, Hickson D, She HS, Sparrow JT, Via DP, Gotto AM Jr, Pownall HJ, Biochim Biophys Acta 1984 794 274 280 10.1016/0005-2760(84)90156-5 6733137 (Pubitemid 14098832)
4. Distribution of phospholipid transfer protein in human plasma: presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive. Oka T, Kujiraoka T, Ito M, Egashira T, Takahashi S, Nanjee MN, Miller NE, Metso J, Olkkonen VM, Ehnholm C, Jauhiainen M, Hattori H, J Lipid Res 2000 41 1651 1657 11013307
5. Quantitation of the active and low-active forms of human plasma phospholipid transfer protein by ELISA. Siggins S, Karkkainen M, Tenhunen J, Metso J, Tahvanainen E, Olkkonen VM, Jauhiainen M, Ehnholm C, J Lipid Res 2004 45 387 395 14617737 (Pubitemid 38228837)
6. Active plasma phospholipid transfer protein is associated with apoA-I- but not apoE-containing lipoproteins. Cheung MC, Albers JJ, J Lipid Res 2006 47 1315 1321 10.1194/jlr.M600042-JLR200 16520487 (Pubitemid 43830724)
7. Regulation of murine plasma phospholipid transfer protein activity and mRNA levels by lipopolysaccharide and high cholesterol diet. Jiang XC, Bruce C, J Biol Chem 1995 270 17133 17138 10.1074/jbc.270.29.17133 7615508
8. Phospholipid transfer protein is regulated by liver X receptors in vivo. Cao G, Beyer TP, Yang XP, Schmidt RJ, Zhang Y, Bensch WR, Kauffman RF, Gao H, Ryan TP, Liang Y, Eacho PI, Jiang XC, J Biol Chem 2002 277 39561 39565 10.1074/jbc.M207187200 12177004 (Pubitemid 35190935)
9. Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression. Valenta DT, Ogier N, Bradshaw G, Black AS, Bonnet DJ, Lagrost L, Curtiss LK, Desrumaux CM, Arterioscler Thromb Vasc Biol 2006 26 1572 1578 10.1161/01.ATV.0000225700.43836.ae 16675720 (Pubitemid 44288985)
10. Absence of endogenous phospholipid transfer protein impairs ABCA1-dependent efflux of cholesterol from macrophage foam cells. Lee-Rueckert M, Vikstedt R, Metso J, Ehnholm C, Kovanen PT, Jauhiainen M, J Lipid Res 2006 47 1725 1732 10.1194/jlr.M600051-JLR200 16687660 (Pubitemid 44222823)
11. Phospholipid transfer protein is present in human atherosclerotic lesions and is expressed by macrophages and foam cells. Desrumaux CM, Mak PA, Boisvert WA, Masson D, Stupack D, Jauhiainen M, Ehnholm C, Curtiss LK, J Lipid Res 2003 44 1453 1461 10.1194/jlr.M200281-JLR200 12730304 (Pubitemid 37279589)
12. Cell-associated and extracellular phospholipid transfer protein in human coronary atherosclerosis. O'Brien KD, Vuletic S, McDonald TO, Wolfbauer G, Lewis K, Tu AY, Marcovina S, Wight TN, Chait A, Albers JJ, Circulation 2003 108 270 274 10.1161/01.CIR.0000079163.97653.CD 12835223 (Pubitemid 36899015)
13. Liver phospholipid transfer protein (PLTP) expression with a PLTP-null background promotes very low density lipoprotein production. Yazdanyar A, Jiang XC, Hepatology 2012 56 576 584. 10.1002/hep.25648 22367708
14. Glucose regulates the transcription of human genes relevant to HDL metabolism: responsive elements for peroxisome proliferator-activated receptor are involved in the regulation of phospholipid transfer protein. Tu AY, Albers JJ, Diabetes 2001 50 1851 1856 10.2337/diabetes.50.8.1851 11473048 (Pubitemid 33641606)
15. Plasma phospholipid transfer protein activity is lowered by 24-h insulin and acipimox administration: blunted response to insulin in type 2 diabetic patients. Riemens SC, van Tol A, Sluiter WJ, Dullaart RP, Diabetes 1999 48 1631 1637 10.2337/diabetes.48.8.1631 10426383 (Pubitemid 29356873)
16. Influence of insulin sensitivity and the TaqIB cholesteryl ester transfer protein gene polymorphism on plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities and their response to hyperinsulinemia in non-diabetic men. Riemens SC, Van Tol A, Stulp BK, Dullaart RP, J Lipid Res 1999 40 1467 1474 10428983 (Pubitemid 29379987)
17. Modulation of the phospholipid transfer protein-mediated transfer of phospholipids by diacylglycerols. Lalanne F, Motta C, Pafumi Y, Lairon D, Ponsin G, J Lipid Res 2001 42 142 149 11160376 (Pubitemid 32142870)
18. Functional analysis of the transcriptional activity of the mouse phospholipid transfer protein gene. Tu AY, Albers JJ, Biochem Biophys Res Commun 2001 287 921 926 10.1006/bbrc.2001.5687 11573953 (Pubitemid 32953564)
19. Characterization of the mouse gene encoding phospholipid transfer protein. Tu AY, Chen H, Johnson KA, Paigen B, Albers JJ, Gene 1997 188 115 118 10.1016/S0378-1119(96)00793-7 9099868 (Pubitemid 27140010)
20. The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions. Laffitte BA, Joseph SB, Chen M, Castrillo A, Repa J, Wilpitz D, Mangelsdorf D, Tontonoz P, Mol Cell Biol 2003 23 2182 2191 10.1128/MCB.23.6.2182-2191.2003 12612088 (Pubitemid 36278826)
21. Differences in reactivity of antibodies to active versus inactive PLTP significantly impacts PLTP measurement. Murdoch SJ, Wolfbauer G, Kennedy H, Marcovina SM, Carr MC, Albers JJ, J Lipid Res 2002 43 281 289 11861670 (Pubitemid 34184015)
22. LXR-SREBP-1c-phospholipid transfer protein axis controls very low density lipoprotein (VLDL) particle size. Okazaki H, Goldstein JL, Brown MS, Liang G, J Biol Chem 2010 285 6801 6810 10.1074/jbc.M109.079459 20037162
23. Structure and phospholipid transfer activity of human PLTP: analysis by molecular modeling and site-directed mutagenesis. Huuskonen J, Wohlfahrt G, Jauhiainen M, Ehnholm C, Teleman O, Olkkonen VM, J Lipid Res 1999 40 1123 1130 10357844 (Pubitemid 29287883)
24. Cholesteryl ester transfer protein and phospholipid transfer protein have no overlapping functions in vivo. Kawano K, Qin SC, Lin M, Tall AR, Jiang XC, J Biol Chem 2000 275 29477 29481 10.1074/jbc.M003523200 10893412 (Pubitemid 32043823)
25. Isolation and characterization of a phospholipid transfer protein (LTP-II) from human plasma. Tollefson JH, Ravnik S, Albers JJ, J Lipid Res 1988 29 1593 1602 2854151 (Pubitemid 19030527)
26. Interaction of plasma high density lipoproteins with dimyristoyllecithin multilamellar liposomes. Tall AR, Hogan V, Askinazi L, Small DM, Biochemistry 1978 17 322 326 10.1021/bi00595a020 202301 (Pubitemid 8270220)
27. Plasma phospholipid transfer protein enhances transfer and exchange of phospholipids between very low density lipoproteins and high density lipoproteins during lipolysis. Tall AR, Krumholz S, Olivecrona T, Deckelbaum RJ, J Lipid Res 1985 26 842 851 4031662 (Pubitemid 15046448)
28. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. Jauhiainen M, Metso J, Pahlman R, Blomqvist S, van Tol A, Ehnholm C, J Biol Chem 1993 268 4032 4036 8440695 (Pubitemid 23072937)
29. Phospholipid transfer is a prerequisite for PLTP-mediated HDL conversion. Huuskonen J, Olkkonen VM, Ehnholm C, Metso J, Julkunen I, Jauhiainen M, Biochemistry 2000 39 16092 16098 10.1021/bi0019287 11123937 (Pubitemid 32038272)
30. Triglyceride-enrichment of high density lipoproteins enhances their remodeling by phospholipid transfer protein. Rye KA, Jauhiainen M, Barter PJ, Ehnholm C, J Lipid Res 1998 39 613 622 9548593 (Pubitemid 28158403)
31. Plasma phospholipid transfer protein. Adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoprotein (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL. Foger B, Santamarina-Fojo S, Shamburek RD, Parrot CL, Talley GD, Brewer HB Jr, J Biol Chem 1997 272 27393 27400 10.1074/jbc.272.43.27393 9341191 (Pubitemid 27452707)
32. Increased atherosclerotic lesions in apoE mice with plasma phospholipid transfer protein overexpression. Yang XP, Yan D, Qiao C, Liu RJ, Chen JG, Li J, Schneider M, Lagrost L, Xiao X, Jiang XC, Arterioscler Thromb Vasc Biol 2003 23 1601 1607 10.1161/01.ATV.0000085841.55248.13 12855484 (Pubitemid 37108204)
33. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. Jiang X, Francone OL, Bruce C, Milne R, Mar J, Walsh A, Breslow JL, Tall AR, J Clin Invest 1996 98 2373 2380 10.1172/JCI119050 8941656 (Pubitemid 26394213)
34. Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice. van Haperen R, van Tol A, Vermeulen P, Jauhiainen M, van Gent T, van den Berg P, Ehnholm S, Grosveld F, van der Kamp A, de Crom R, Arterioscler Thromb Vasc Biol 2000 20 1082 1088 10.1161/01.ATV.20.4.1082 10764677 (Pubitemid 30207586)
35. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. Jiang XC, Bruce C, Mar J, Lin M, Ji Y, Francone OL, Tall AR, J Clin Invest 1999 103 907 914 10.1172/JCI5578 10079112 (Pubitemid 29152637)
36. Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hyper catabolism, and accumulate apoA-IV-rich lamellar lipoproteins. Qin S, Kawano K, Bruce C, Lin M, Bisgaier C, Tall AR, Jiang X, J Lipid Res 2000 41 269 276 10681411 (Pubitemid 30117868)
37. PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity. Yan D, Navab M, Bruce C, Fogelman AM, Jiang XC, J Lipid Res 2004 45 1852 1858 10.1194/jlr.M400053-JLR200 15258196 (Pubitemid 40990877)
38. Phospholipid transfer protein interacts with and stabilizes ATP-binding cassette transporter A1 and enhances cholesterol efflux from cells. Oram JF, Wolfbauer G, Vaughan AM, Tang C, Albers JJ, J Biol Chem 2003 278 52379 52385 10.1074/jbc.M310695200 14559902 (Pubitemid 38035828)
39. An amphipathic helical region of the N-terminal barrel of phospholipid transfer protein is critical for ABCA1-dependent cholesterol efflux. Oram JF, Wolfbauer G, Tang C, Davidson WS, Albers JJ, J Biol Chem 2008 283 11541 11549 10.1074/jbc.M800117200 18287097
40. Acute elevation of plasma PLTP activity strongly increases pre-existing atherosclerosis. Moerland M, Samyn H, van Gent T, van Haperen R, Dallinga-Thie G, Grosveld F, van Tol A, de Crom R, Arterioscler Thromb Vasc Biol 2008 28 1277 1282 10.1161/ATVBAHA.108.165084 18421000
41. Elevation of systemic PLTP, but not macrophage-PLTP, impairs macrophage reverse cholesterol transport in transgenic mice. Samyn H, Moerland M, van Gent T, van Haperen R, Grosveld F, van Tol A, de Crom R, Atherosclerosis 2009 204 429 434 10.1016/j.atherosclerosis.2008.10.020 19100548
42. Cholesterol efflux from macrophage foam cells is enhanced by active phospholipid transfer protein through generation of two types of acceptor particles. Vikstedt R, Metso J, Hakala J, Olkkonen VM, Ehnholm C, Jauhiainen M, Biochemistry 2007 46 11979 11986 10.1021/bi700833h 17900150 (Pubitemid 47623766)
43. Atherogenic, enlarged, and dysfunctional HDL in human PLTP/apoA-I double transgenic mice. Moerland M, Samyn H, van Gent T, Jauhiainen M, Metso J, van Haperen R, Grosveld F, van Tol A, de Crom R, J Lipid Res 2007 48 2622 2631 10.1194/jlr.M700020-JLR200 17761633 (Pubitemid 350272847)
44. Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification. de Vries R, Groen AK, Perton FG, Dallinga-Thie GM, van Wijland MJ, Dikkeschei LD, Wolffenbuttel BH, van Tol A, Dullaart RP, Atherosclerosis 2008 196 733 741 10.1016/j.atherosclerosis.2006.12.027 17275009
45. Increased phospholipid transfer protein activity associated with the impaired cellular cholesterol efflux in type 2 diabetic subjects with coronary artery disease. Attia N, Nakbi A, Smaoui M, Chaaba R, Moulin P, Hammami S, Hamda KB, Chanussot F, Hammami M, Tohoku J Exp Med 2007 213 129 137 10.1620/tjem.213.129 17917406 (Pubitemid 47554873)
46. Overexpression of apolipoprotein F reduces HDL cholesterol levels in vivo. Lagor WR, Brown RJ, Toh SA, Millar JS, Fuki IV, de la Llera-Moya M, Yuen T, Rothblat G, Billheimer JT, Rader DJ, Arterioscler Thromb Vasc Biol 2009 29 40 46 10.1161/ATVBAHA.108.177105 19008531
47. Recent progress in understanding apolipoprotein B. Young SG, Circulation 1990 82 1574 1594 10.1161/01.CIR.82.5.1574 1977530 (Pubitemid 20367961)
48. Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Chen SH, Habib G, Yang CY, Gu ZW, Lee BR, Weng SA, Silberman SR, Cai SJ, Deslypere JP, Rosseneu M, et al. Science 1987 238 363 366 10.1126/science.3659919 3659919 (Pubitemid 17151728)
49. A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine. Powell LM, Wallis SC, Pease RJ, Edwards YH, Knott TJ, Scott J, Cell 1987 50 831 840 10.1016/0092-8674(87)90510-1 3621347
50. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG, J Clin Invest 1973 52 1544 1568 10.1172/JCI107332 4718953
51. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. Brunzell JD, Albers JJ, Chait A, Grundy SM, Groszek E, McDonald GB, J Lipid Res 1983 24 147 155 6403642 (Pubitemid 13080348)
52. Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study. Duvillard L, Pont F, Florentin E, Galland-Jos C, Gambert P, Verges B, Eur J Clin Invest 2000 30 685 694 10.1046/j.1365-2362.2000.00702.x 10964160 (Pubitemid 30604069)
53. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity. Riches FM, Watts GF, Naoumova RP, Kelly JM, Croft KD, Thompson GR, Int J Obes Relat Metab Disord 1998 22 414 423 10.1038/sj.ijo.0800602 9622338 (Pubitemid 28211969)
54. The microsomal triglyceride transfer protein catalyzes the post-translational assembly of apolipoprotein B-100 very low density lipoprotein in McA-RH7777 cells. Rustaeus S, Stillemark P, Lindberg K, Gordon D, Olofsson SO, J Biol Chem 1998 273 5196 5203 10.1074/jbc.273.9.5196 9478974 (Pubitemid 28108682)
55. Studies on the assembly of apolipoprotein B-100- and B-48-containing very low density lipoproteins in McA-RH7777 cells. Boren J, Rustaeus S, Olofsson SO, J Biol Chem 1994 269 25879 25888 7929292 (Pubitemid 24336289)
56. Normal activity of microsomal triglyceride transfer protein is required for the oleate-induced secretion of very low density lipoproteins containing apolipoprotein B from McA-RH7777 cells. Wang Y, McLeod RS, Yao Z, J Biol Chem 1997 272 12272 12278 10.1074/jbc.272.19.12272 9139669 (Pubitemid 27203310)
57. Chylomicron-sized lipid particles are formed in the setting of apolipoprotein B deficiency. Hamilton RL, Wong JS, Cham CM, Nielsen LB, Young SG, J Lipid Res 1998 39 1543 1557 9717714 (Pubitemid 28377918)
58. Fish oil fatty acids impair VLDL assembly and/or secretion by cultured rat hepatocytes. Lang CA, Davis RA, J Lipid Res 1990 31 2079 2086 2150855
59. N-3 fatty acids stimulate intracellular degradation of apoprotein B in rat hepatocytes. Wang H, Chen X, Fisher EA, J Clin Invest 1993 91 1380 1389 10.1172/JCI116340 8473489 (Pubitemid 23127336)
60. Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes. Sparks JD, Sparks CE, J Biol Chem 1990 265 8854 8862 2187873
61. Lipid balance in HepG2 cells: active synthesis and impaired mobilization. Gibbons GF, Khurana R, Odwell A, Seelaender MC, J Lipid Res 1994 35 1801 1808 7852857 (Pubitemid 24331282)
62. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency. Jiang XC, Qin S, Qiao C, Kawano K, Lin M, Skold A, Xiao X, Tall AR, Nat Med 2001 7 847 852 10.1038/89977 11433351 (Pubitemid 32691641)
63. Elevation of plasma phospholipid transfer protein in transgenic mice increases VLDL secretion. Lie J, de Crom R, van Gent T, van Haperen R, Scheek L, Lankhuizen I, van Tol A, J Lipid Res 2002 43 1875 1880 10.1194/jlr.M200166- JLR200 12401886 (Pubitemid 35315805)
64. Relationship of phospholipid transfer protein activity to HDL and apolipoprotein B-containing lipoproteins in subjects with and without type 1 diabetes. Colhoun HM, Taskinen MR, Otvos JD, Van Den Berg P, O'Connor J, Van Tol A, Diabetes 2002 51 3300 3305 10.2337/diabetes.51.11.3300 12401722 (Pubitemid 35246977)
65. Worsening of Diet-Induced Atherosclerosis in a New Model of Transgenic Rabbit Expressing the Human Plasma Phospholipid Transfer Protein. Masson D, Deckert V, Gautier T, Klein A, Desrumaux C, Viglietta C, Pais de Barros JP, Le Guern N, Grober J, Labbe J, Menetrier F, Ripoll PJ, Leroux-Coyau M, Jolivet G, Houdebine LM, Lagrost L, Arterioscler Thromb Vasc Biol 2011 31 766 774 10.1161/ATVBAHA.110.215756 21252068
66. Phospholipid transfer protein-deficient mice absorb less cholesterol. Liu R, Iqbal J, Yeang C, Wang DQ, Hussain MM, Jiang XC, Arterioscler Thromb Vasc Biol 2007 27 2014 2021 10.1161/ATVBAHA.107.149914 17641249 (Pubitemid 47312312)
67. Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E. Jiang XC, Tall AR, Qin S, Lin M, Schneider M, Lalanne F, Deckert V, Desrumaux C, Athias A, Witztum JL, Lagrost L, J Biol Chem 2002 277 31850 31856 10.1074/jbc.M205077200 12105225 (Pubitemid 34968992)
68. Cholesterol accumulation is increased in macrophages of phospholipid transfer protein-deficient mice: normalization by dietary alpha-tocopherol supplementation. Ogier N, Klein A, Deckert V, Athias A, Bessede G, Le Guern N, Lagrost L, Desrumaux C, Arterioscler Thromb Vasc Biol 2007 27 2407 2412 10.1161/ATVBAHA.107.151753 17717294 (Pubitemid 350203957)
69. Phospholipid transfer protein deficiency impairs apolipoprotein-B secretion from hepatocytes by stimulating a proteolytic pathway through a relative deficiency of vitamin E and an increase in intracellular oxidants. Jiang XC, Li Z, Liu R, Yang XP, Pan M, Lagrost L, Fisher EA, Williams KJ, J Biol Chem 2005 280 18336 18340 15734742 (Pubitemid 41389080)
70. Phospholipid transfer protein activity is determined by type 2 diabetes mellitus and metabolic syndrome, and is positively associated with serum transaminases. Dullaart RP, de Vries R, Dallinga-Thie GM, Sluiter WJ, van Tol A, Clin Endocrinol (Oxf) 2008 68 375 381 (Pubitemid 351257854)
71. LPS, TLR4 and infectious disease diversity. Miller SI, Ernst RK, Bader MW, Nat Rev Microbiol 2005 3 36 46 10.1038/nrmicro1068 15608698 (Pubitemid 40028467)
72. Neutralization and transfer of lipopolysaccharide by phospholipid transfer protein. Hailman E, Albers JJ, Wolfbauer G, Tu AY, Wright SD, J Biol Chem 1996 271 12172 12178 10.1074/jbc.271.21.12172 8647810 (Pubitemid 26160875)
73. Effect of plasma phospholipid transfer protein deficiency on lethal endotoxemia in mice. Gautier T, Klein A, Deckert V, Desrumaux C, Ogier N, Sberna AL, Paul C, Le Guern N, Athias A, Montange T, Monier S, Piard F, Jiang XC, Masson D, Lagrost L, J Biol Chem 2008 283 18702 18710 10.1074/jbc.M802802200 18458077
74. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Erdmann J, Grosshennig A, Braund PS, Konig IR, Hengstenberg C, Hall AS, Linsel-Nitschke P, Kathiresan S, Wright B, Tregouet DA, Cambien F, Bruse P, Aherrahrou Z, Wagner AK, Stark K, Schwartz SM, Salomaa V, Elosua R, Melander O, Voight BF, O'Donnell CJ, Peltonen L, Siscovick DS, Altshuler D, Merlini PA, Peyvandi F, Bernardinelli L, Ardissino D, Schillert A, Blankenberg S, Zeller T, et al. Nat Genet 2009 41 280 282 10.1038/ng.307 19198612
75. A common allele on chromosome 9 associated with coronary heart disease. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox DR, Hinds DA, Pennacchio LA, Tybjaerg-Hansen A, Folsom AR, Boerwinkle E, Hobbs HH, Cohen JC, Science 2007 316 1488 1491 10.1126/science.1142447 17478681 (Pubitemid 46906617)
76. Genomewide association analysis of coronary artery disease. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, Dixon RJ, Meitinger T, Braund P, Wichmann HE, Barrett JH, Konig IR, Stevens SE, Szymczak S, Tregouet DA, Iles MM, Pahlke F, Pollard H, Lieb W, Cambien F, Fischer M, Ouwehand W, Blankenberg S, Balmforth AJ, Baessler A, Ball SG, Strom TM, Braenne I, Gieger C, Deloukas P, et al. N Engl J Med 2007 357 443 453 10.1056/NEJMoa072366 17634449 (Pubitemid 47204873)
77. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, Heath SC, Timpson NJ, Najjar SS, Stringham HM, Strait J, Duren WL, Maschio A, Busonero F, Mulas A, Albai G, Swift AJ, Morken MA, Narisu N, Bennett D, Parish S, Shen H, Galan P, Meneton P, Hercberg S, Zelenika D, Chen WM, Li Y, Scott LJ, Scheet PA, et al. Nat Genet 2008 40 161 169 10.1038/ng.76 18193043 (Pubitemid 351171403)
78. Genetic variation at the phospholipid transfer protein locus affects its activity and high-density lipoprotein size and is a novel marker of cardiovascular disease susceptibility. Vergeer M, Boekholdt SM, Sandhu MS, Ricketts SL, Wareham NJ, Brown MJ, de Faire U, Leander K, Gigante B, Kavousi M, Hofman A, Uitterlinden AG, van Duijn CM, Witteman JC, Jukema JW, Schadt EE, van der Schoot E, Kastelein JJ, Khaw KT, Dullaart RP, van Tol A, Trip MD, Dallinga-Thie GM, Circulation 2010 122 470 477 10.1161/CIRCULATIONAHA.109.912519 20644014
79. Common variants at 30 loci contribute to polygenic dyslipidemia. Kathiresan S, Willer CJ, Peloso GM, Demissie S, Musunuru K, Schadt EE, Kaplan L, Bennett D, Li Y, Tanaka T, Voight BF, Bonnycastle LL, Jackson AU, Crawford G, Surti A, Guiducci C, Burtt NP, Parish S, Clarke R, Zelenika D, Kubalanza KA, Morken MA, Scott LJ, Stringham HM, Galan P, Swift AJ, Kuusisto J, Bergman RN, Sundvall J, Laakso M, et al. Nat Genet 2009 41 56 65 10.1038/ng.291 19060906
80. Phospholipid transfer protein. van Tol A, Curr Opin Lipidol 2002 13 135 139 10.1097/00041433-200204000-00004 11891415 (Pubitemid 34280764)
81. High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease. Schlitt A, Bickel C, Thumma P, Blankenberg S, Rupprecht HJ, Meyer J, Jiang XC, Arterioscler Thromb Vasc Biol 2003 23 1857 1862 10.1161/01.ATV.0000094433.98445.7F 12947020 (Pubitemid 37254875)
82. Relation of baseline plasma phospholipid transfer protein (PLTP) activity to left ventricular systolic dysfunction in patients referred for coronary angiography. Cavusoglu E, Marmur JD, Chhabra S, Chopra V, Eng C, Jiang XC, Atherosclerosis 2009 207 261 265 10.1016/j.atherosclerosis.2009.04.011 19446293
83. Plasma PLTP activity is inversely associated with HDL-C levels. Chen X, Sun A, Mansoor A, Zou Y, Ge J, Lazar JM, Jiang XC, Nutr Metab (Lond) 2009 6 49 10.1186/1743-7075-6-49
84. Low phospholipid transfer protein (PLTP) is a risk factor for peripheral atherosclerosis. Schgoer W, Mueller T, Jauhiainen M, Wehinger A, Gander R, Tancevski I, Salzmann K, Eller P, Ritsch A, Haltmayer M, Ehnholm C, Patsch JR, Foeger B, Atherosclerosis 2008 196 219 226 10.1016/j.atherosclerosis.2007.04.046 17553507
85. Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein. van Haperen R, van Tol A, van Gent T, Scheek L, Visser P, van der Kamp A, Grosveld F, de Crom R, J Biol Chem 2002 277 48938 48943 10.1074/jbc.M209128200 12372822 (Pubitemid 35470864)
86. Macrophage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development. Vikstedt R, Ye D, Metso J, Hildebrand RB, Van Berkel TJ, Ehnholm C, Jauhiainen M, Van Eck M, Arterioscler Thromb Vasc Biol 2007 27 578 586 10.1161/01.ATV.0000254815.49414.be 17170377
87. Elevated expression of phospholipid transfer protein in bone marrow derived cells causes atherosclerosis. van Haperen R, Samyn H, Moerland M, van Gent T, Peeters M, Grosveld F, van Tol A, de Crom R, PLoS One 2008 3 2255 10.1371/journal.pone.0002255 18509527
88. Macrophage phospholipid transfer protein deficiency and ApoE secretion: impact on mouse plasma cholesterol levels and atherosclerosis. Liu R, Hojjati MR, Devlin CM, Hansen IH, Jiang XC, Arterioscler Thromb Vasc Biol 2007 27 190 196 10.1161/01.ATV.0000249721.96666.e5 17038631 (Pubitemid 46360398)
89. Macrophage PLTP is atheroprotective in LDLr-deficient mice with systemic PLTP deficiency. Valenta DT, Bulgrien JJ, Bonnet DJ, Curtiss LK, J Lipid Res 2008 49 24 32 10.1194/jlr.M700228-JLR200 17928634